Aase syndrome
Aase syndrome
A rare genetic disorder characterized by anemia and skeletal abnormalities

Aase syndrome is a rare genetic disorder that is primarily characterized by anemia and various skeletal abnormalities. It is typically inherited in an autosomal dominant pattern, meaning that a single copy of the altered gene in each cell is sufficient to cause the disorder.
Signs and symptoms
Individuals with Aase syndrome often present with a range of clinical features, which may include:
- Anemia: A reduction in the number of red blood cells, leading to symptoms such as fatigue, pallor, and shortness of breath.
- Skeletal abnormalities: These may include triphalangeal thumb, cleft palate, and joint contractures.
- Growth retardation: Affected individuals may experience delayed growth and development.
- Congenital heart defects: Some individuals may have structural heart problems present at birth.
Genetics
Aase syndrome is caused by mutations in genes that are involved in the development of blood cells and skeletal structures. The disorder is inherited in an autosomal dominant manner, which means that an affected individual has a 50% chance of passing the condition on to their offspring.
Diagnosis
The diagnosis of Aase syndrome is based on clinical evaluation, identification of characteristic physical findings, and specialized tests such as:
- Complete blood count (CBC) to assess anemia.
- Bone marrow biopsy to evaluate blood cell production.
- Genetic testing to identify mutations associated with the syndrome.
Management
Management of Aase syndrome is typically symptomatic and supportive. Treatment options may include:
- Blood transfusions to manage severe anemia.
- Surgery to correct skeletal abnormalities or congenital heart defects.
- Physical therapy to improve joint mobility and muscle strength.
Prognosis
The prognosis for individuals with Aase syndrome varies depending on the severity of the symptoms and the presence of associated complications. With appropriate medical care, many individuals can lead relatively normal lives.
Related pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian